<html>
<head>PUBMED IDs for RAFT1</head>
<body bgcolor='#C5F0F2'><h1>RAFT1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/10325225/'>Interaction of RAFT1 with gephyrin required for rapamycin-sensitive signaling.</a> May 15  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10436010/'>Protein kinase activity and identification of a toxic effector domain of the target of rapamycin TOR proteins in yeast.</a> August 6  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/11069888/'>Regulation of cellular growth by the Drosophila target of rapamycin dTOR.</a> November 9  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11579461/'>GPHN, a novel partner gene fused to MLL in a leukemia with t(11;14)(q23;q24).</a> October 2  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/12101249/'>The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation.</a> July 9  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/15356022/'>Low frequency of BRAFT1796A mutations in childhood thyroid carcinomas.</a> September 10  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15547711/'>The BRAFT1796A transversion is a prevalent mutational event in human thyroid microcarcinoma.</a> November 18  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15899815/'>Targeted expression of BRAFV600E in thyroid cells of transgenic mice results in papillary thyroid cancers that undergo dedifferentiation.</a> May 19  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16896265/'>No evidence of ARAF, CRAF and MET mutations in BRAFT1799A negative human papillary thyroid carcinoma.</a> August 10  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/23295297/'>MicroRNAs miR-146-5p and let-7f as prognostic tools for aggressive papillary thyroid carcinoma: a case report.</a> December 16  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/26107686/'>GLI1 Transcription Factor Affects Tumor Aggressiveness in Patients With Papillary Thyroid Cancers.</a> September 17  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/28030816/'>Down-regulation of 14q32-encoded miRNAs and tumor suppressor role for miR-654-3p in papillary thyroid cancer.</a> December 29  2016<br></body></html>
